Watchdog groups want President Trump's new coronavirus vaccine czar to disclose all of his ties to drug companies. More

Two top FDA officials will recuse themselves from Covid-19 vaccine approval decisions since they are joining a Trump push for approval. More

After years of undermining health policy to aid their Big Pharma patrons, patient advocacy groups are making claims to federal pandemic relief. More

Until advocates are willing to take on Big Pharma, reform efforts have no chance. More

Three senators on a revived subcommittee received more than $100,000 each from drugmakers. More

Amid ongoing debate over the role the pharmaceutical industry plays in shaping health policy, a new analysis finds that patient groups funded by drug makers generally support corporate interests, few groups have policies governing industry backing, and transparency is often lacking. More

At the same time that more doctors were prescribing stimulants, a new analysis finds that 1 in 18 U.S. physicians received some form of payment from drug companies that were marketing these medicines, notably ADHD pills often prescribed for children. And the researchers suggested the financial ties may have partly contributed to the rise in prescriptions. More

Pharmaceutical companies have long turned to physicians to deliver key marketing messages to their colleagues, patients, and the public. These companies are now investing in patients who have gained trust and stature within a patient community. These patients speak as everyday people with medical conditions, as relatable as a friend from high school. More

A National Institutes of Health database, which we’re making public for the first time, shows that researchers have reported more than 8,000 “significant” financial conflicts, potentially influencing their work. More